Skip to main content
. 2022 Jan 17;11(2):463. doi: 10.3390/jcm11020463

Table 5.

Therapeutic effects of the treatments for improvement of primary Sjögren syndrome without ocular surface inflammation.

95% CI
Treatments ß Lower Upper p
Oral pilocarpine 0.991 0.962 1.022 0.578
Low-dose oral steroid 0.992 0.901 1.091 0.862
Tear substitutes
 Carbomer gel 1.060 1.019 1.102 0.003 *
 Lanoline ointment 1.171 1.134 1.211 <0.001 *
 Diquafosol 3% 1.372 1.116 1.685 0.003 *
Topical cyclosporine 0.861 0.686 1.080 0.196
Punctal plug insertion
 Lower eyelid 2.967 2.259 3.897 <0.001 *
 Upper eyelid 1.848 1.315 2.598 <0.001 *

Adjustment for corneal staining score. * p < 0.05.